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146 Oxidative stress biomarkers in cystic ﬁbrosis and non-
cystic ﬁbrosis bronchiectasis patients
G. Olveira Fuster1, A. Dorado Galindo1, C. Olveira Fuster1,
F. Espildora Hernandez1, N. Porras Perez1, E. Garcı´a Fuentes1, I. Gaspar1,
R. Jimeno1, J.L. De la Cruz1, M. Murri1. 1Hospital Carlos Haya, Ma´laga, Spain
Objetives: Oxidative stress is believed to play an important role in the pathophys-
iology of cystic ﬁbrosis (CF). Many factors may contribute to increased oxidative
stress in CF, as the disease combines the increased production of reactive oxygen
species (ROS) with impaired antioxidant protection. The aim, therefore, of this
study was to evaluate oxidative stress using different biomarkers (both plasma and
intracellular in peripheral blood leukocytes) in a group of clinically stable adult
patients with bronchiectasis (CF and non-CF) and compare the results with a group
of healthy controls.
Methods: This cross-sectional study included 90 patients with a diagnosis of
bronchiectasis with and without CF, periodically monitored in the adult bronchiecta-
sis/CF unit at a university hospital. A control group comprised 50 healthy subjects,
matched with respect to patient sex, age and nutritional status.
The intracellular oxidative stress biomarkers (mitochondrial membrane potential,
superoxide anion and hydrogen peroxide and intracellular glutathione) were an-
alyzed in white blood cells as total leukocytes, neutrophils, lymphocytes and
monocytes. The plasma oxidative stress biomarkers (total antioxidant capacity,
glutathione peroxidase activity, superoxide dismutase activity, catalase activity,
8-iso-prostaglandin F2a, TBARs) were measured.
Conclusions: Cell and plasma markers of oxidative stress were raised in the patients
with bronchiectasis as compared with the controls and no differences depending on
the cause of the bronchiectasis (CF vs non-CF) were found.
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Bronchiectasis is an airway disease characterized by thickening of the bronchial
wall, chronic inﬂammation and destruction of affected bronchi. Underlying aetiolo-
gies include severe pulmonary infection and cystic ﬁbrosis (CF), however in a large
number of patients with non-CF related bronchiectasis (NCFB) no cause is found.
This study evaluated airway inﬂammatory markers in patients with CF and NCFB
so as to facilitate the identiﬁcation of common or different treatment options.
Bronchoalveolar lavage (BAL) was performed in patients with CF, NCFB and
controls (n = 10). Neutrophil elastase (NE), MMP-2 and MMP-9 activity was
quantiﬁed by ﬂuorometric assay and zymography. Levels of pro-inﬂammatory
mediators (IL-8 and IL-18) and anti-inﬂammatory cytokines (IL-4 and IL-10) were
measured by ELISA.
Patients with CF had elevated levels of NE (p< 0.0001), MMP-2 and MMP-9
activity (P< 0.01) when compared to controls, while protease levels in NCFB
BAL was at an intermediate level between CF and control samples. Levels of
IL-8 were elevated in NCFB BAL when compared to controls (P< 0.05) but below
concentrations observed in CF (P< 0.05). IL-18 levels in CF and NCFB BAL were
similar to that of controls. Equal levels of IL-10 and IL-4 cytokine were observed
in both CF and NCFB groups which were elevated above control values (P< 0.05).
This study demonstrates that while similar inﬂammatory markers are present in the
airways of both CF and NCFB, they are also signiﬁcantly different from each other.
Results indicate that appropriate management of the protease burden and the anti-
inﬂammatory response may reduce deterioration of pulmonary function associated
with both CF and NCFB.
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Oxidative stress has a relevant role in the pathogenesis of pulmonary disease in
CF. BAP test is a validated photometric test on capillary blood samples for the
determination of biological antioxidant potential. BAP test normal value is >2200
microvol/L. d-ROM test is a validated test wich measures the oxidant ability of a
plasma sample. d-ROM test normal value is <300UCARR. We performed BAP test,
d-ROM test and CRP (C-reactive protein) in 35 CF patients (19 male, mean age 18.6
range 43−4, mean FEV1: 59% pr, range 23–120%, st.dev 30). Our results support
the condition of high oxidative stress in CF: mean BAP test was 1542 UCARR
(range 2304–697, st.dev 509.26), mean d-ROM test was 310 microvol/L (range
132–586, st.dev 95.12). d-ROM was signiﬁcantly higher in 22 pts with elevated
PCR than in 13 pts with normal PCR (mean 355, range 238–586, st.dev 81.09
and mean 234, range 132–351, st.dev 64.6 respectively, p: 0.000). Chi-square test
also resulted statistical signiﬁcance (p: 0.000). The dosage of d-ROM test pre- and
post-antibiotic e.v. treatment in 7 pts showed a statistically signiﬁcant improvement
(mean value pre-: 352, range 302–381, st.dev 30, mean value post-: 269, range
182–393, st.dev 73, p: 0.007) according to the reduction in CRP values. BAP test
doesn’t appear to correlate with CRP in CF even during exacerbations and antibiotic
ev therapy. Our results show that, d-ROM and BAP tests may have a role in the
oxidative status assessment. The correlation between oxidative stress (d-ROM test)
and inﬂammation (CRP) in CF patients was also shown.
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Objectives: The zinc ﬁnger protein A20 inhibits NF-úB activation in response to
LPS. A20 expression is reduced in CF and accompanied by persistent activation
of NF-kB and release of inﬂammatory cytokines [1]. An A20 inducing drug is
not currently available. Gibberellin (GA) is a plant diterpenoid involved in the
regulation of plant development via induction of A20/ZnF proteins [2]. GA was
shown to have anti-inﬂammatory effects in diabetic mice although the mechanism
was not explored [3]. We hypothesise that GA induces A20 and examine its anti-
inﬂammatory properties in airway epithelial cells.
Methods: 16HBE14o− cells (n = 3) and primary nasal epithelial cells (NECs) from
healthy subjects (n = 2) were pre-treated with 30 mM GA (Sigma) for 1h prior to
the addition of 10 mM LPS (P. aeruginosa, Sigma) for 0−24h. A20 induction was
determined by qPCR while IL-8 release was measured by ELISA.
Conclusions: A20 mRNA was maximally induced in 16HBE14o− 1h after LPS
stimulation. Thereafter, A20 expression fell back to basal levels. However, in
16HBE14o− pretreated with GA, A20 remained at maximal levels 24h after LPS
stimulation. The increase in A20 expression was accompanied by reduced IL-8
release in GA treated cells. Reduced IL-8 secretion was conﬁrmed in primary NECs
treated with LPS where a 34% reduction was observed with GA pretreatment. Our
ﬁndings conﬁrm the reported anti-inﬂammatory effects of GA in airway epithelial
cells for the ﬁrst time. Future studies will explore this mechanism further and will
investigate the effect of GA in CF epithelial cells.
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